{"id":"W2947266573","doi":"10.1200/jco.2019.37.15_suppl.e14125","title":"Real-life use of nivolumab and pembrolizumab in four adult university teaching hospitals in Québec, Canada.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Nivolumab; Pembrolizumab; Medicine; Discontinuation; Adverse effect; Population; Melanoma; Internal medicine; Renal cell carcinoma; Lung cancer; Cancer; Oncology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465998,0.000360903,0.0002364713,0.0008844871,0.001916836,0.0009813799,0.0009313098,0.0006759875,0.003114148],"category_scores_gemma":[0.001409917,0.0003311877,0.0002855321,0.001919346,0.0006636875,0.0003587414,0.0006682911,0.0006052987,0.0004959374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03273324,"about_ca_system_score_gemma":0.02159288,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9616745,"about_ca_topic_score_gemma":0.9788556,"domain_scores_codex":[0.9991591,0.00007756289,0.00006554006,0.0001636861,0.0002246312,0.0003095535],"domain_scores_gemma":[0.9962009,0.0002321783,0.00114937,0.00006481956,0.000885521,0.001467248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000132133,0.0000896754,0.9869754,0.00007641985,0.00003664343,0.0006487536,0.0007194679,0.000191332,0.0004169335,0.00005662136,0.002501897,0.00815472],"study_design_scores_gemma":[0.00001385335,0.0000971831,0.9951508,0.00004393493,0.0000134286,0.0002657954,0.001600045,0.0003783664,0.0001079097,0.00001093726,0.002301136,0.00001655291],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893048,0.001133124,0.0001351589,0.0007862209,0.00001871474,0.0001159788,0.005172822,0.00002893784,0.003304254],"genre_scores_gemma":[0.994541,0.0006219391,0.0002469311,0.0005330351,0.00002030457,0.00003626709,0.001770383,0.000006645157,0.002223619],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03832549,"threshold_uncertainty_score":0.2374974,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04672971601381915,"score_gpt":0.3583926393468246,"score_spread":0.3116629233330054,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}